Vasocom, Inc.
United StatesFDA applicant, unverified
- Devices
- 3
What Vasocom, Inc. makes
Vasocom, Inc. manufactures continuous renal replacement therapy (CRRT) systems, including the PHYSIOFLOW ENDURO, a portable hemofiltration device designed for prolonged extracorporeal blood purification, and the PHYSIOFLOW SYSTEM, a modular platform for acute kidney support. The PHYSIOFLOW Q-LINK serves as a wireless connectivity module for remote monitoring and data transmission in CRRT applications.
The company’s devices are classified as Class II under FDA regulations and are authorised through the 510(k) clearance process. These products are listed in the FDA’s 510(k) database. Vasocom, Inc. is headquartered in the United States.
Catalogue
Physioflow Enduro Ref K103283
Regimes: 510(k) Registry: 510(k)Physioflow System Ref K060387
Regimes: 510(k) Registry: 510(k)Physioflow Q-Link Ref K140102
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Vasocom, Inc. have in the registry?
The registry currently lists 3 devices for Vasocom, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Vasocom, Inc.'s devices?
Among its 3 most recently registered devices, Vasocom, Inc. has devices listed in FDA 510(k) (3 devices).
What risk classes do Vasocom, Inc.'s devices fall under?
Among its 3 most recently registered devices, the classes recorded for Vasocom, Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Vasocom, Inc. in the registry?
The most recently registered devices listed for Vasocom, Inc. include PHYSIOFLOW ENDURO, PHYSIOFLOW SYSTEM and PHYSIOFLOW Q-LINK.